Article info
Extended reports
Baseline comorbidity levels in biologic and standard DMARD treated patients with rheumatoid arthritis: results from a national patient register
Other Contributors
- , 2Members of BSRBR Control Centre Consortium (see the appendix)
- Correspondence to:
Professor A Silman
ARC Unit, University of Manchester, Manchester, UK; a.silman{at}manchester.ac.uk
Citation
Baseline comorbidity levels in biologic and standard DMARD treated patients with rheumatoid arthritis: results from a national patient register
Publication history
- Accepted November 4, 2005
- First published December 8, 2005.
Online issue publication
June 12, 2006
Article Versions
- Previous version (8 December 2005).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2006 by Annals of the Rheumatic Diseases